RNA-seq of pancreatic cancer cells (1012 and 9805) derived from a genetically engineered mouse model, which harbor the inducible KrasG12D allele
Ontology highlight
ABSTRACT: Pancreatic adenocarcinoma (PDAC) is a lethal disease and it is the most common type of pancreatic cancer. Majority of the pancreatic cancers harbor alterations in the Kras gene. Currently there are no approved drugs that target Kras directly and it's downstream effect on the epigenome remains unknown. In this study, we investigated the epigenetic landscape of pancreatic cancer cells which harbor the inducible KrasG12D allele. We performed RNA-seq, ChIP-seq against 6 different histone marks, ATAC-seq and RRBS to assess the changes in the epigenome after oncogenic KrasG12D induction.
INSTRUMENT(S): Illumina NovaSeq 6000
ORGANISM(S): Mus musculus
SUBMITTER: Gwen Lomberk
PROVIDER: E-MTAB-10897 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA